Lessons for the nascent regenerative medicine industry from the biotech sector

Regenerative Medicine

Volumn 2, Issue 5, 2007, Pages 753-756

  Mason, Chris ^a   Dunnill, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILICON;

BIOPROCESS; BIOTECHNOLOGY; BONE MARROW TRANSPLANTATION; CAPITAL; COMMERCIAL PHENOMENA; COMPUTER PROGRAM; CONTRACT; DRUG INDUSTRY; DRUG MARKETING; EDITORIAL; FINANCIAL MANAGEMENT; GENETICS; INFORMATION TECHNOLOGY; INVESTMENT; MEDICAL RESEARCH; PATENT; PRIORITY JOURNAL; PROFIT; REGENERATIVE MEDICINE; SEMICONDUCTOR; SOCIAL MARKETING; TISSUE ENGINEERING;

BIOTECHNOLOGY; HUMANS; INDUSTRY; REGENERATIVE MEDICINE;

EID: 35048901402     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.5.753     Document Type: Editorial

References (3)

1. Pisano GP: Science Business: The Promise, the Reality, and the Future of Biotech. Harvard Business School Press, MA, USA, ISBN 1-59139-84D-1, (2006).
2. Kemp P: History of regenerative medicine: looking backwards to move forwards. Regen. Med. 1(5), 653-669 (2006).
3. Pisano GP: Can Science Be a Business? Lessons from Biotech. Harv. Bus. Rev. 1st October (2006).